Clinical Trials Browser

Recruiting × INDUSTRY × efineptakin alfa × Clear all

NCT06344715 2024-04-03

Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)